Journal of the Advanced Practitioner in Oncology

Not yet evaluated

About the journal

Journal of the Advanced Practitioner in Oncology is a journal in United States. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

ISSN
2150-0886 · 2150-0878
Country
United States
Access
Not open access / not declared

Index listings

  • PUBMED · 2024-01-05
Indexing
PUBMED
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1364

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

36

i10-index

199

From OpenAlex open data (CC0).

Editorial & policy2
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Identity & continuity3
Alternate titles
JAdPrO
Source type
journal
NLM unique ID (PubMed)
101550346
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Economic and Financial Impacts of Cancer
  • Cancer survivorship and care
  • Cancer survivorship and care
  • Economic and Financial Impacts of Cancer
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • CAR-T cell therapy research
  • Palliative Care and End-of-Life Issues
Show all subjects (50)
  • Cancer Treatment and Pharmacology
  • Palliative Care and End-of-Life Issues
  • Cancer Treatment and Pharmacology
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • CAR-T cell therapy research
  • Advances in Oncology and Radiotherapy
  • Advances in Oncology and Radiotherapy
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Childhood Cancer Survivors' Quality of Life
  • Colorectal Cancer Treatments and Studies
  • Lymphoma Diagnosis and Treatment
  • Advanced Breast Cancer Therapies
  • Colorectal Cancer Treatments and Studies
  • Advanced Breast Cancer Therapies
  • Childhood Cancer Survivors' Quality of Life
  • Lymphoma Diagnosis and Treatment
  • Nursing Roles and Practices
  • HER2/EGFR in Cancer Research
  • Neutropenia and Cancer Infections
  • HER2/EGFR in Cancer Research
  • Neutropenia and Cancer Infections
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Nursing Roles and Practices
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Interprofessional Education and Collaboration
  • Pancreatic and Hepatic Oncology Research

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: